Table 1 Genetic variations and irregular splicing of GPHN characterized in patients with neurological disorders.

From: Complex regulation of Gephyrin splicing is a determinant of inhibitory postsynaptic diversity

Diseases

Genetic variations

Previous exon nomenclature

References

Novel exon nomenclature

Seizure, ASD, and SCZD

Deletion

Fusion exon 3–5

Lionel et al., 2013

Fusion exon 10–14

IGE

Deletion

Fusion exon 1–4

Dejanovic et al. 2014

Fusion exon 1–12

IGE

Deletion

Fusion exon 4–10

Dejanovic et al. 2014

Fusion exon 12–27

TLE

Irregular splicing

Splice junction exon 3–9

Forstera et al., 2010

Splice junction exon 5–16

TLE

Irregular splicing

Splice junction exon 5–9

Forstera et al., 2010

Splice junction exon 12–16

TLE

Irregular splicing

Splice junction exon 4–8

Forstera et al., 2010

Splice junction exon 10–15

TLE

Irregular splicing

Junction exon 3–5

Forstera et al., 2010

Junction exon 5–12

TLE

Irregular splicing

Junction exon 5–8

Forstera et al., 2010

Junction exon 12–15

EE

Missense mutation G375D

Exon 17 G > A

Dejanovic et al., 2015

Exon 29 G > A

  1. TLE temporal lobe epilepsy, IGE idiopathic generalized epilepsy, EE epileptic encephalopathy, ASD autism syndrome disorder, SCZD schizophrenia.
  2. Neurological diseases are referenced in the first column and below the table, while genetic variations, previous exon annotations, references, and new exon annotations are indicated in four separated columns.